FDA Calendar for Par Pharmaceutical Companies, Inc. (PRX)

| Register (free)
Par Pharmaceutical Companies, Inc. is a holding company that, principally through its wholly owned operating subsidiary, Par Pharmaceutical, Inc., is engaged in the business of developing, licensing, manufacturing and distributing generic and branded drugs in the United States. The Company operates in two segments: Par Pharmaceutical, its generic products division, and Strativa Pharmaceuticals, its branded products division. On March 31, 2009, the Company acquired Nascobal Nasal Spray from QOL Medical, LLC.


Drug Pipeline

Drug NameType Of DrugFDA StatusDrug Phase
Miconazole MBT Other Pending DecisionNDA


Events

No future events listed at this time, please check back later.
1 past event(s) found. Click here to view them.

Add New Event

In order to write a comment you must first login.

Login or Register (for free!)

Add Event

PRX

$38.00
0.30 +0.80%
2/3/2012 4:03:00 PM

Sponsors

Other Links